1-20 of 80
rosiglitazone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In This Issue of Diabetes

Max Bingham, PhD
Journal: Diabetes
Diabetes 2024;73(2):149–150
https://doi.org/10.2337/db24-ti02
Published: 19 January 2024
View article titled, In This Issue of <em>Diabetes</em>
Open the PDF for In This Issue of <em>Diabetes</em> in another window
Journal Articles

GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice

Ellen C. Furber, Karissa Hyatt, Kyla Collins, Xinxin Yu, Brian A. Droz, Adrienne Holland, Jessica L. Friedrich, Samantha Wojnicki, Debra L. Konkol, Libbey S. O’Farrell, Hana E. Baker, Tamer Coskun, Philipp E. Scherer, Christine M. Kusminski, Michael E. Christe, Kyle W. Sloop, Ricardo J. Samms
Journal: Diabetes
Diabetes 2024;73(2):292–305
https://doi.org/10.2337/db23-0172
Published: 07 November 2023
View article titled, GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice
Open the PDF for GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice in another window
Meeting Abstracts

2-OR: Exosomes from Adipose Tissue Macrophages Can Mediate Insulin-Sensitizing Effects of Rosiglitazone

THERESA V. ROHM, FELIPE C.G. REIS, ROI ISAAC, MILES PASZEK, GAUTAM BANDYOPADHYAY, JERROLD M. OLEFSKY
Journal: Diabetes
Diabetes 2022;71(Supplement_1):2-OR
https://doi.org/10.2337/db22-2-OR
Published: 01 June 2022
View article titled, 2-OR: Exosomes from Adipose Tissue Macrophages Can Mediate Insulin-Sensitizing Effects of Rosiglitazone
Journal Articles

PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment

Longhua Liu, Lihong Fan, Michelle Chan, Michael J. Kraakman, Jing Yang, Yong Fan, Nicole Aaron, Qianfen Wan, Maria Alicia Carrillo-Sepulveda, Alan R. Tall, Ira Tabas, Domenico Accili, Li Qiang
Journal: Diabetes
Diabetes 2020;69(8):1793–1803
https://doi.org/10.2337/db20-0217
Published: 14 May 2020
View article titled, PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment
Open the PDF for PPARγ Deacetylation Confers the Antiatherogenic Effect and Improves Endothelial Function in Diabetes Treatment in another window
Meeting Abstracts

2423-PUB: Rosiglitazone Has a Neutral Effect on the Risk of Dementia in Type 2 Diabetes Patients

CHIN-HSIAO TSENG
Journal: Diabetes
Diabetes 2019;68(Supplement_1):2423-PUB
https://doi.org/10.2337/db19-2423-PUB
Published: 01 June 2019
View article titled, 2423-PUB: Rosiglitazone Has a Neutral Effect on the Risk of Dementia in Type 2 Diabetes Patients
Meeting Abstracts

1953-P: PPARγ Agonism and FGF-21 Synergize to Robustly Induce Browning of White Fat

TOBIAS KROON, MATTHEW J. HARMS, DANIEL NILSSON, ANNA LINDBLOM, PETER GENNEMARK, GAVIN O'MAHONY, VICTORIA OSINSKI, COLEEN A. MCNAMARA, JEREMIE BOUCHER
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1953-P
https://doi.org/10.2337/db19-1953-P
Published: 01 June 2019
View article titled, 1953-P: PPARγ Agonism and FGF-21 Synergize to Robustly Induce Browning of White Fat
Meeting Abstracts

Rosiglitazone Increases Visceral and Subcutaneous Fat in Youth with Type 2 Diabetes (T2D) in the TODAY Study

RUBAN DHALIWAL, JOHN A. SHEPHERD, LAURE EL GHORMLI, KENNETH C. COPELAND, MITCHELL GEFFNER, JANINE HIGGINS, LYNNE L. LEVITSKY, KRISTEN J. NADEAU, RUTH S. WEINSTOCK, NEIL H. WHITE
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1341-P
https://doi.org/10.2337/db18-1341-P
Published: 01 July 2018
View article titled, Rosiglitazone Increases Visceral and Subcutaneous Fat in Youth with Type 2 Diabetes (T2D) in the TODAY Study
Journal Articles

A Pharmacogenetic Approach to the Treatment of Patients With PPARG Mutations

Maura Agostini, Erik Schoenmakers, Junaid Beig, Louise Fairall, Istvan Szatmari, Odelia Rajanayagam, Frederick W. Muskett, Claire Adams, A. David Marais, Stephen O’Rahilly, Robert K. Semple, Laszlo Nagy, Amit R. Majithia, John W.R. Schwabe, Dirk J. Blom, Rinki Murphy, Krishna Chatterjee, David B. Savage
Journal: Diabetes
Diabetes 2018;67(6):1086–1092
https://doi.org/10.2337/db17-1236
Published: 05 April 2018
View article titled, A Pharmacogenetic Approach to the Treatment of Patients With <em>PPARG</em> Mutations
Open the PDF for A Pharmacogenetic Approach to the Treatment of Patients With <em>PPARG</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice

Emi Ishida, Ja Young Kim-Muller, Domenico Accili
Journal: Diabetes
Diabetes 2017;66(8):2092–2101
https://doi.org/10.2337/db16-1213
Published: 15 May 2017
View article titled, Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in <em>db/db</em> Mice
Open the PDF for Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in <em>db/db</em> Mice in another window
Includes: Supplementary data
Journal Articles

FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues

Tali Garin-Shkolnik, Assaf Rudich, Gökhan S. Hotamisligil, Menachem Rubinstein
Journal: Diabetes
Diabetes 2014;63(3):900–911
https://doi.org/10.2337/db13-0436
Published: 13 February 2014
View article titled, FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues
Open the PDF for FABP4 Attenuates PPARγ and Adipogenesis and Is Inversely Correlated With PPARγ in Adipose Tissues in another window
Journal Articles

High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: Involvement of Peroxisome Proliferator–Activated Receptor γ Signaling

Wing Yan So, Qianni Cheng, Lihua Chen, Carmella Evans-Molina, Aimin Xu, Karen S.L. Lam, Po Sing Leung
Journal: Diabetes
Diabetes 2013;62(11):3751–3759
https://doi.org/10.2337/db13-0645
Published: 18 October 2013
View article titled, High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: <subtitle>Involvement of Peroxisome Proliferator–Activated Receptor γ Signaling</subtitle>
Open the PDF for High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: <subtitle>Involvement of Peroxisome Proliferator–Activated Receptor γ Signaling</subtitle> in another window
Includes: Supplementary data
Journal Articles

In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas

Jordi Lanuza-Masdeu, M. Isabel Arévalo, Cristina Vila, Albert Barberà, Ramon Gomis, Carme Caelles
Journal: Diabetes
Diabetes 2013;62(7):2308–2317
https://doi.org/10.2337/db12-1097
Published: 14 June 2013
View article titled, In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas
Open the PDF for In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas in another window
Includes: Supplementary data
Journal Articles

Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model

Antonio Cittadini, Raffaele Napoli, Maria Gaia Monti, Domenica Rea, Salvatore Longobardi, Paolo Antonio Netti, Marion Walser, Mariateresa Samà, Gianluca Aimaretti, Jörgen Isgaard, Luigi Saccà
Journal: Diabetes
Diabetes 2012;61(4):944–953
https://doi.org/10.2337/db11-1132
Published: 14 March 2012
View article titled, Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Open the PDF for Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model in another window
Journal Articles

Thiazolidinedione Treatment Decreases Oxidative Stress in Spontaneously Hypertensive Heart Failure Rats Through Attenuation of Inducible Nitric Oxide Synthase–Mediated Lipid Radical Formation

Maria B. Kadiiska, Marcelo G. Bonini, Christine Ruggiero, Ellen Cleland, Shawna Wicks, Krisztian Stadler
Journal: Diabetes
Diabetes 2012;61(3):586–596
https://doi.org/10.2337/db11-1091
Published: 13 February 2012
View article titled, Thiazolidinedione Treatment Decreases Oxidative Stress in Spontaneously Hypertensive Heart Failure Rats Through Attenuation of Inducible Nitric Oxide Synthase–Mediated Lipid Radical Formation
Open the PDF for Thiazolidinedione Treatment Decreases Oxidative Stress in Spontaneously Hypertensive Heart Failure Rats Through Attenuation of Inducible Nitric Oxide Synthase–Mediated Lipid Radical Formation in another window
Includes: Supplementary data
Journal Articles

Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis

Laura D. Sardone, Richard Renlund, Thomas L. Willett, Ivan G. Fantus, Marc D. Grynpas
Journal: Diabetes
Diabetes 2011;60(12):3271–3278
https://doi.org/10.2337/db10-1672
Published: 13 November 2011
View article titled, Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis
Open the PDF for Effect of Rosiglitazone on Bone Quality in a Rat Model of Insulin Resistance and Osteoporosis in another window
Includes: Supplementary data
Journal Articles

Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

Steven E. Kahn, John M. Lachin, Bernard Zinman, Steven M. Haffner, R. Paul Aftring, Gitanjali Paul, Barbara G. Kravitz, William H. Herman, Giancarlo Viberti, Rury R. Holman, and the ADOPT Study Group
Journal: Diabetes
Diabetes 2011;60(5):1552–1560
https://doi.org/10.2337/db10-1392
Published: 23 April 2011
View article titled, Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT
Open the PDF for Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT in another window
Journal Articles

Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome

William Baldwin, Steven McRae, George Marek, David Wymer, Varinderpal Pannu, Chris Baylis, Richard J. Johnson, Yuri Y. Sautin
Journal: Diabetes
Diabetes 2011;60(4):1258–1269
https://doi.org/10.2337/db10-0916
Published: 22 March 2011
View article titled, Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome
Open the PDF for Hyperuricemia as a Mediator of the Proinflammatory Endocrine Imbalance in the Adipose Tissue in a Murine Model of the Metabolic Syndrome in another window
Includes: Supplementary data
Journal Articles

A Newly Identified CG301269 Improves Lipid and Glucose Metabolism Without Body Weight Gain Through Activation of Peroxisome Proliferator–Activated Receptor α and γ

Hyun Woo Jeong, Joo-Won Lee, Woo Sik Kim, Sung Sik Choe, Kyung-Hee Kim, Ho Seon Park, Hyun Jung Shin, Gha Young Lee, Dongkyu Shin, Hanjae Lee, Jun Hee Lee, Eun Bok Choi, Hyeon Kyu Lee, Heekyoung Chung, Seung Bum Park, Kyong Soo Park, Hyo-Soo Kim, Seonggu Ro, Jae Bum Kim
Journal: Diabetes
Diabetes 2011;60(2):496–506
https://doi.org/10.2337/db09-1145
Published: 21 January 2011
View article titled, A Newly Identified CG301269 Improves Lipid and Glucose Metabolism Without Body Weight Gain Through Activation of Peroxisome Proliferator–Activated Receptor α and γ
Open the PDF for A Newly Identified CG301269 Improves Lipid and Glucose Metabolism Without Body Weight Gain Through Activation of Peroxisome Proliferator–Activated Receptor α and γ in another window
Includes: Supplementary data
Journal Articles

Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance

José María Moreno-Navarrete, Rubén Martínez-Barricarte, Victoria Catalán, Mònica Sabater, Javier Gómez-Ambrosi, Francisco José Ortega, Wifredo Ricart, Mathias Blüher, Gema Frühbeck, Santiago Rodríguez de Cordoba, José Manuel Fernández-Real
Journal: Diabetes
Diabetes 2010;59(1):200–209
https://doi.org/10.2337/db09-0700
Published: 15 October 2009
View article titled, Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance
Open the PDF for Complement Factor H Is Expressed in Adipose Tissue in Association With Insulin Resistance in another window
Journal Articles

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

Jing Xu, David J. Lloyd, Clarence Hale, Shanaka Stanislaus, Michelle Chen, Glenn Sivits, Steven Vonderfecht, Randy Hecht, Yue-Sheng Li, Richard A. Lindberg, Jin-Long Chen, Dae Young Jung, Zhiyou Zhang, Hwi-Jin Ko, Jason K. Kim, Murielle M. Véniant
Journal: Diabetes
Diabetes 2009;58(1):250–259
https://doi.org/10.2337/db08-0392
Published: 01 January 2009
View article titled, Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
Open the PDF for Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice in another window
Includes: Supplementary data